BioRestorative Therapies/$BRTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About BioRestorative Therapies
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
Ticker
$BRTX
Sector
Primary listing
Employees
14
Headquarters
Website
BRTX Metrics
BasicAdvanced
$5.9m
-
-$1.58
0.27
-
Price and volume
Market cap
$5.9m
Beta
0.27
52-week high
$2.05
52-week low
$0.19
Average daily volume
2m
Financial strength
Current ratio
0.843
Quick ratio
0.797
Total debt to equity
11.852
Profitability
EBITDA (TTM)
-15.437
Gross margin (TTM)
93.37%
Net profit margin (TTM)
-3,959.40%
Operating margin (TTM)
-4,350.04%
Revenue per employee (TTM)
$30,000
Management effectiveness
Return on assets (TTM)
-119.56%
Return on equity (TTM)
-320.47%
Valuation
Price to revenue (TTM)
5.832
Price to book
6.04
Price to tangible book (TTM)
-10.82
Price to free cash flow (TTM)
-0.192
Free cash flow yield (TTM)
-519.89%
Free cash flow per share (TTM)
-1.213
Growth
Revenue change (TTM)
-10.30%
Earnings per share change (TTM)
36.93%
3-year revenue growth (CAGR)
44.27%
10-year revenue growth (CAGR)
-5.43%
3-year earnings per share growth (CAGR)
-24.33%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for BioRestorative Therapies stock?
BioRestorative Therapies (BRTX) has a market cap of $5.9M as of May 04, 2026.
What is the P/E ratio for BioRestorative Therapies stock?
The price to earnings (P/E) ratio for BioRestorative Therapies (BRTX) stock is 0 as of May 04, 2026.
Does BioRestorative Therapies stock pay dividends?
No, BioRestorative Therapies (BRTX) stock does not pay dividends to its shareholders as of May 04, 2026.
When is the next BioRestorative Therapies dividend payment date?
BioRestorative Therapies (BRTX) stock does not pay dividends to its shareholders.
What is the beta indicator for BioRestorative Therapies?
BioRestorative Therapies (BRTX) has a beta rating of 0.27. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.